Skip to main content
. 2020 Sep 2;10:550950. doi: 10.3389/fonc.2020.550950

TABLE 3.

The clinical outcomes of the patient cohorts in our study.

Clinical outcomes (n = 55)
Failure pattern 10-year control rate (n [%])
Ipsilateral breast tumor recurrence 1 (1.82%)
Regional nodal failure 0
Distant metastasis 1 (1.82%)
Disease-free survival 52 (94.55%)
Overall survival 54 (98.18%)